Kuo W, de Bruijne M, Petersen J, Nasserinejad K, Ozturk H, Chen Y, et al. Diagnosis of bronchiectasis and airway wall thickening in children with cystic fibrosis: objective airway-artery quantification. Eur Radiol. 2017;27(11):4680–9.

Article  PubMed  PubMed Central  Google Scholar 

Diaz AA, Young TP, Maselli DJ, Martinez CH, Gill R, Nardelli P, et al. Quantitative CT measures of Bronchiectasis in smokers. Chest. 2017;151(6):1255–62.

Article  PubMed  Google Scholar 

Tiddens HAWM, van der Meerburg JJ, Ciet P. The radiological diagnosis of bronchiectasis: what’s in a name? Eur Respir Rev off J Eur Respir Soc. 2020;29(156).

Aliberti S, Goeminne PC, O’Donnell AE, Aksamit TR, Al-Jahdali H, Barker AF, et al. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Lancet Respir Med. 2022;10(3):298–306.

Article  PubMed  Google Scholar 

Dhar R, Singh S, Talwar D, Murali Mohan BV, Tripathi SK, Swarnakar R et al. Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry. Eur Respir J. 2023;61(1).

Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3).

Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn SJ, Floto AR, et al. British thoracic Society Guideline for bronchiectasis in adults. Thorax. 2019;74(Suppl 1):1–69.

Article  PubMed  Google Scholar 

Araújo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon T, et al. Standardised classification of the aetiology of bronchiectasis using an objective algorithm. The European respiratory journal. Volume 50. England; 2017.

Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet (London England). 2018;392(10150):880–90.

Article  PubMed  Google Scholar 

Dicker AJ, Lonergan M, Keir HR, Smith AH, Pollock J, Finch S, et al. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study. Lancet Respir Med. 2021;9(8):885–96.

Article  CAS  PubMed  Google Scholar 

Mac Aogáin M, Narayana JK, Tiew PY, Ali NABM, Yong VFL, Jaggi TK, et al. Integrative microbiomics in bronchiectasis exacerbations. Nat Med. 2021;27(4):688–99.

Article  PubMed  Google Scholar 

Narayana JK, Aliberti S, Mac Aogáin M, Jaggi TK, Ali NABM, Ivan FX, et al. Microbial Dysregulation of the gut-lung Axis in Bronchiectasis. Am J Respir Crit Care Med. 2023;207(7):908–20.

Article  CAS  PubMed  Google Scholar 

Suarez-Cuartin G, Smith A, Abo-Leyah H, Rodrigo-Troyano A, Perea L, Vidal S, et al. Anti-pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis. Respir Med. 2017;128:1–6.

Article  PubMed  Google Scholar 

Mac Aogáin M, Chandrasekaran R, Lim AYH, Low TB, Tan GL, Hassan T et al. Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study. Eur Respir J. 2018;52(1).

Mac Aogáin M, Tiew PY, Lim AYH, Low TB, Tan GL, Hassan T, et al. Distinct immunoallertypes of Disease and High frequencies of Sensitization in Non-cystic Fibrosis Bronchiectasis. Am J Respir Crit Care Med. 2019;199(7):842–53.

Article  PubMed  Google Scholar 

Saleh AD, Chalmers JD, De Soyza A, Fardon TC, Koustas SO, Scott J, et al. The heterogeneity of systemic inflammation in bronchiectasis. Respir Med. 2017;127:33–9.

Article  PubMed  Google Scholar 

Chalmers JD, Moffitt KL, Suarez-Cuartin G, Sibila O, Finch S, Furrie E, et al. Neutrophil elastase activity is Associated with exacerbations and lung function decline in Bronchiectasis. Am J Respir Crit Care Med. 2017;195(10):1384–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oriano M, Gramegna A, Terranova L, Sotgiu G, Sulaiman I, Ruggiero L et al. Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis. Eur Respir J. 2020;56(4).

Keir HR, Shoemark A, Huang JTJ, Chalmers JD. SPLUNC1 is a novel marker of disease severity and airway infection in bronchiectasis. The European respiratory journal. Volume 58. England; 2021.

Metersky M, Chalmers J. Bronchiectasis insanity: doing the same thing over and over again and expecting different results? F1000Research. 2019;8.

Muñoz G, de Gracia J, Buxó M, Alvarez A, Vendrell M. Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial. Eur Respir J. 2018;51(1).

Herrero-Cortina B, Lee AL, Oliveira A, O’Neill B, Jácome C, Dal Corso S et al. European Respiratory Society statement on airway clearance techniques in adults with bronchiectasis. Eur Respir J. 2023.

O’Donnell AE, Barker AF, Ilowite JS, Fick RB. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest. 1998;113(5):1329–34.

Article  PubMed  Google Scholar 

Bilton D, Tino G, Barker AF, Chambers DC, De Soyza A, Dupont LJA, et al. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial. Thorax. 2014;69(12):1073–9.

Article  PubMed  Google Scholar 

Pollock J, Chalmers JD. The immunomodulatory effects of macrolide antibiotics in respiratory disease. Pulm Pharmacol Ther. 2021;71:102095.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet (London England). 2012;380(9842):660–7.

Article  CAS  PubMed  Google Scholar 

Altenburg J, de Graaff CS, Stienstra Y, Sloos JH, van Haren EHJ, Koppers RJH, et al. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA. 2013;309(12):1251–9.

Article  CAS  PubMed  Google Scholar 

Serisier DJ, Martin ML, McGuckin MA, Lourie R, Chen AC, Brain B, et al. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial. JAMA. 2013;309(12):1260–7.

Article  CAS  PubMed  Google Scholar 

Vicendese D, Yerkovich S, Grimwood K, Valery PC, Byrnes CA, Morris PS, et al. Long-term azithromycin in Children with Bronchiectasis unrelated to cystic fibrosis: treatment effects over Time. Chest. 2023;163(1):52–63.

Article  CAS  PubMed  Google Scholar 

Laska IF, Crichton ML, Shoemark A, Chalmers JD. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis. Lancet Respir Med. 2019;7(10):855–69.

Article  CAS  PubMed  Google Scholar 

Chalmers JD, McDonnell MJ, Rutherford R, Davidson J, Finch S, Crichton M, et al. The generalizability of bronchiectasis randomized controlled trials: a multicentre cohort study. Respir Med. 2016;112:51–8.

Article  PubMed  Google Scholar 

Chalmers JD, Haworth CS, Metersky ML, Loebinger MR, Blasi F, Sibila O, et al. Phase 2 trial of the DPP-1 inhibitor Brensocatib in Bronchiectasis. N Engl J Med. 2020;383(22):2127–37.

Article  CAS  PubMed  Google Scholar 

Martins M, Keir HR, Chalmers JD. Endotypes in bronchiectasis: moving towards precision medicine. A narrative review. Pulmonology. 2023.

Agarwal R, Aggarwal AN, Dhooria S, Singh Sehgal I, Garg M, Saikia B, et al. A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2016;47(2):490–8.

Article  CAS  PubMed  Google Scholar 

Agarwal R, Dhooria S, Singh Sehgal I, Aggarwal AN, Garg M, Saikia B, et al. A Randomized Trial of Itraconazole vs Prednisolone in Acute-Stage allergic bronchopulmonary aspergillosis complicating asthma. Chest. 2018;153(3):656–64.

Article  PubMed  Google Scholar 

Agarwal R, Muthu V, Sehgal IS, Dhooria S, Prasad KT, Garg M et al. A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2022;59(4).

Jin M, Douglass JA, Elborn JS, Agarwal R, Calhoun WJ, Lazarewicz S, et al. Omalizumab in allergic bronchopulmonary aspergillosis: a systematic review and Meta-analysis. J Allergy Clin Immunol Pract. 2023;11(3):896–905.

Article  CAS  PubMed  Google Scholar 

Muthu V, Dhooria S, Sehgal IS, Prasad KT, Rudramurthy SM, Aggarwal AN, et al. Nebulized amphotericin B for preventing exacerbations in allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis. Pulm Pharmacol Ther. 2023;81:102226.

Article  CAS  PubMed  Google Scholar 

Kwok WC, Tam TCC, Lam DCL, Ip MSM, Ho JCM. Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis. Clin Respir J. 2023;17(6):548–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bendien SA, Kroes HA, van Hal LH, Braunstahl G-J, Broeders ME, Oud KT et al. Real-world effectiveness of interleukin-5/5Ra targeted biologics in severe eosinophilic asthma with comorbid bronchiectasis. J Allergy Clin Immunol Pract. 2023.

Jayaram L, Vandal AC, Chang CL, Lewis C, Tong C, Tuffery C et al. Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial. Eur Respir J. 2022;59(6).

Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M et al. Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. United States; 2021.

Mall MA, Danahay H, Boucher RC. Emerging concepts and therapies for Mucoobstructive Lung Disease. Ann Am Thorac Soc. 2018;15(Suppl 3):S216–26.

Article  PubMed  PubMed Central